Forbes, J. F., Sestak, I., Howell, A., Bonanni, B., Bundred, N., Levy, C., . . . Cuzick, J. (2016). Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): A double-blind, randomised controlled trial. Lancet.
Styl ChicagoForbes, John F., et al. "Anastrozole Versus Tamoxifen for the Prevention of Locoregional and Contralateral Breast Cancer in Postmenopausal Women With Locally Excised Ductal Carcinoma in Situ (IBIS-II DCIS): A Double-blind, Randomised Controlled Trial." Lancet 2016.
Citace podle MLAForbes, John F., et al. "Anastrozole Versus Tamoxifen for the Prevention of Locoregional and Contralateral Breast Cancer in Postmenopausal Women With Locally Excised Ductal Carcinoma in Situ (IBIS-II DCIS): A Double-blind, Randomised Controlled Trial." Lancet 2016.